American Financial Group’s Augmedix, Inc. Common Stock AUGX Stock Holding History

American Financial Group’s Portfolio AUGX Stock Details AUGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-500,000	Closed	-$1.18M	–	67
2024 Q3	$1.18M	Hold	500,000	–	–	0.5%	34
2024 Q2	$440K	Hold	500,000	–	–	0.19%	54
2024 Q1	$2.04M	Hold	500,000	–	–	0.77%	30
2023 Q4	$2.92M	Hold	500,000	–	–	1.08%	27
2023 Q3	$2.58M	Hold	500,000	–	–	0.88%	30
2023 Q2	$2.4M	Hold	500,000	–	–	0.74%	35
2023 Q1	$870K	Hold	500,000	–	–	0.27%	54
2022 Q4	$780K	Hold	500,000	–	–	0.26%	58
2022 Q3	$725K	Hold	500,000	–	–	0.25%	57
2022 Q2	$900K	Hold	500,000	–	–	0.3%	52
2022 Q1	$1.47M	Hold	500,000	–	–	0.45%	46
2021 Q4	$1.57M	Buy	+500,000	New	+$1.81M	0.43%	47

American Financial Group's AUGX Position: Q4 2024 in Review

American Financial Group sold out of Augmedix, Inc. Common Stock (AUGX) in Q4 2024, closing a stake of 500,000 shares — an estimated $1.18M sold.

American Financial Group first reported a position in AUGX in Q4 2021 and held it in 12 quarters. The position peaked at $2.92M in Q4 2023. 0 funds tracked by Wall St. Rank hold AUGX as of Q4 2024.

American Financial Group reported no remaining Augmedix, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
American Financial Group sold 500,000 Augmedix, Inc. Common Stock shares in Q4 2024, an estimated $1.18M.
American Financial Group first reported a position in Augmedix, Inc. Common Stock in Q4 2021 and held it in 12 quarters.
American Financial Group's Augmedix, Inc. Common Stock position peaked at $2.92M in Q4 2023.
0 funds tracked by Wall St. Rank held Augmedix, Inc. Common Stock as of Q4 2024.

Based on American Financial Group's 13F filing for Q4 2024, filed 11 Feb 2025.